Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Thaker

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
American Journal of Clinical Oncology|June 13, 2022
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical CancerPaula M Fracasso, Linda R Duska, Premal H Thaker, et al.
Cancer|June 23, 2015
Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancerLauren Z Davis, George M Slavich, Premal H Thaker, et al.
Gynecologic Oncology|March 8, 2020
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?Kathryn A Mills, Tanvi V Joshi, Lindsay West, et al.
Gynecologic Oncology|February 26, 2019
Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid useSarah P Huepenbecker, Sarah E Cusworth, Lindsay M Kuroki, et al.
Cancer Research|July 22, 2025
Multi-omic Characterization of Pre- and Post-neoadjuvant Chemotherapy Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy ResponseMark C Valentine, Mary M Mullen, Emilee N Kotnik, et al.
Gynecologic Oncology Reports|October 11, 2022
Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgeryAbigail S Zamorano, Angela L Mazul, Christine Marx, et al.
American Journal of Obstetrics and Gynecology|April 9, 2008
Impact of vessel maturation on antiangiogenic therapy in ovarian cancerChunhua Lu, Premal H Thaker, Yvonne G Lin, et al.
Gynecologic Oncology|November 30, 2019
Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer preventionNatalie E Griffin, Tommy R Buchanan, Stephanie H Smith, et al.
Npj Imaging|June 3, 2026
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detectionSanskar Thakur, Yixiao Lin, Jinhua Xu, et al.
Cancer Research|January 11, 2007
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancerAparna A Kamat, Tae Jin Kim, Charles N Landen, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
American Journal of Clinical Oncology|June 13, 2022
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical CancerPaula M Fracasso, Linda R Duska, Premal H Thaker, et al.
Cancer|June 23, 2015
Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancerLauren Z Davis, George M Slavich, Premal H Thaker, et al.
Gynecologic Oncology|March 8, 2020
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?Kathryn A Mills, Tanvi V Joshi, Lindsay West, et al.
Gynecologic Oncology|February 26, 2019
Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid useSarah P Huepenbecker, Sarah E Cusworth, Lindsay M Kuroki, et al.
Cancer Research|July 22, 2025
Multi-omic Characterization of Pre- and Post-neoadjuvant Chemotherapy Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy ResponseMark C Valentine, Mary M Mullen, Emilee N Kotnik, et al.
Gynecologic Oncology Reports|October 11, 2022
Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgeryAbigail S Zamorano, Angela L Mazul, Christine Marx, et al.
American Journal of Obstetrics and Gynecology|April 9, 2008
Impact of vessel maturation on antiangiogenic therapy in ovarian cancerChunhua Lu, Premal H Thaker, Yvonne G Lin, et al.
Gynecologic Oncology|November 30, 2019
Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer preventionNatalie E Griffin, Tommy R Buchanan, Stephanie H Smith, et al.
Npj Imaging|June 3, 2026
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detectionSanskar Thakur, Yixiao Lin, Jinhua Xu, et al.
Cancer Research|January 11, 2007
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancerAparna A Kamat, Tae Jin Kim, Charles N Landen, et al.
Pageof 24